Mountaineer Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Mountaineer Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Mountaineer Study Today - Breaking & Trending Today

HER2+ Metastatic Colorectal Cancer: Clinical Trial Data With Tucatinib

Published: July 19, 2023

A panel of oncologists shares comprehensive insight to clinical trial data with tucatinib in patients with HER2+ metastatic colorectal cancer.

Source: onclive.com

Related Topics:

Evolving TestingTreatment StrategiesMetastatic Colorectal CancerClinical Trial Data With TucatinibColorectal CancerHer2 PositiveHer2 CrcHer2 TargetedHer2 TherapyHer2 AmplificationMountaineer TrialMountaineer StudyMountaineer 03Combination TherapyAsco 2023Asco Annual Meeting Novel TherapyDose ModificationDose ReductionAdverse EventsDrug Adverse Event

Dr Foote on the Use of Tucatinib Plus Trastuzumab in HER2-Amplified mCRC

Published: April 10, 2023

Micheal Foote, MD, discusses the use of tucatinib plus trastuzumab compared with chemotherapy in the management of HER2-amplified metastatic colorectal cancer.

Source: onclive.com

Related Topics:

Michael FooteMemorial Sloan Kettering Cancer CenterMetastatic Colorectal CancerHer2 AmplifiedMetastatic Colorectal CancerMountaineer Study